The Thalassemias
Author: D. J. Weatherall
Publisher:
Published: 1983
Total Pages: 186
ISBN-13:
DOWNLOAD EBOOKPosts
Prevention of Thalassaemias and Other Haemoglobin Disorders
Author: Galanello Renzo
Publisher:
Published: 2003
Total Pages: 190
ISBN-13: 9789963623396
DOWNLOAD EBOOKVolume 1 of the Prevention Book presents the principles of a programme for the prevention of the thalassaemia and other haemoglobin disorders, including a description of the various types of disorders requiring prenatal diagnosis, the strategies used for carrier screening, and a number of annexes listing upto date epidemiological and mutation data on thalassaemia. This book was written for use in combination with Volume 2, which describes many of the laboratory protocols in great detail.
The Thalassaemia Syndromes
Author: David J. Weatherall
Publisher: John Wiley & Sons
Published: 2008-04-30
Total Pages: 864
ISBN-13: 0470695943
DOWNLOAD EBOOKIn the new edition of this successful and authoritative book, the thalassaemias are reviewed in detail with respect to their clinical features, cellular pathology, molecular genetics, prevention and treatment. It is aimed at specialists in haematology in the laboratory or clinical setting, particularly in areas where thalassaemia is common either in the native population or in immigrant communities. The fourth edition has been both updated and re-organized. Three new chapters have been added on the link between alpha-thalassaemia and mental retardation, on avoidance and population control and on global epidemiology. Considerable emphasis is placed on molecular pathology reflecting the huge burst of information to have come out of this field in the last few years.
Iron Chelation Therapy
Author: Chaim Hershko
Publisher: Taylor & Francis US
Published: 2002
Total Pages: 290
ISBN-13: 9780306467851
DOWNLOAD EBOOKWithin the last few years, iron research has yielded exciting new insights into the understanding of normal iron homeostasis. Such development, and the evolution of improved strategies of Iron Chelating Therapy require better understanding of the pathophysiology of iron toxicity and the mechanism of action of iron chelating drugs. The timeliness of the present volume is underlined by several significant developments in recent years. New insights have been gained into the molecular basis of aberrant iron handling in hereditary disorders and the pathophysiology of iron overload. This volume highlights the impact of long term Iron Celating Therapy using deferoxamine or the new, but controversial oral iron chelator deferiprone based on experience gained by multicenter trails, with special emphasis on survival, morbidity and drug toxicity; it reviews the development of the new and improved orally effective chelators suitable for clinical use in the near future and examines novel strategies of iron chelating treatment for the control of cell proliferation in malignant disease or malaria.
Thalassemia and Other Hemolytic Anemias
Author: Isam Jaber Al-Zwaini
Publisher: BoD – Books on Demand
Published: 2018-07-11
Total Pages: 140
ISBN-13: 1789233666
DOWNLOAD EBOOKThalassemia is a very common disease first described by pediatrician Thomas Benton Cooley in 1925 who described it in a patient of Italian origin. At that time, it was designated as Cooley's anemia. George Hoyt Whipple, a Nobel prize winner, and W. L. Bradford, a professor of pediatrics at the University of Rochester, coined the term thalassemia in 1936, which in Greek means anemia of the sea (Thalassa means "sea", and emia means "blood"), due to the fact that it is very common in the area of the Mediterranean Sea. This name is actually misleading because it can occur everywhere in the world. Thalassemia is not a single disease; it is rather a group of hereditary disorders of the production of globulin chain of the hemoglobin. Throughout the world, thalassemia affects approximately 4.4 of every 10,000 live births. It represents a major social and emotional impact on the patient and his family and a major burden on health services where the prevalence is high.
Disorders of Hemoglobin
Author: Martin H. Steinberg
Publisher: Cambridge University Press
Published: 2009-08-17
Total Pages: 883
ISBN-13: 0521875196
DOWNLOAD EBOOKCompletely revised new edition of the definitive reference on disorders of hemoglobin.
NORD Guide to Rare Disorders
Author: National Organization for Rare Disorders
Publisher: Lippincott Williams & Wilkins
Published: 2003
Total Pages: 982
ISBN-13: 9780781730631
DOWNLOAD EBOOKNORD Guide to Rare Disorders is a comprehensive, practical, authoritative guide to the diagnosis and management of more than 800 rare diseases. The diseases are discussed in a uniform, easy-to-follow format--a brief description, signs and symptoms, etiology, related disorders, epidemiology, standard treatment, investigational treatment, resources, and references.The book includes a complete directory of orphan drugs, a full-color atlas of visual diagnostic signs, and a Master Resource List of support groups and helpful organizations. An index of symptoms and key words offers physicians valuable assistance in finding the information they need quickly.
Pediatric Hematology
Author: Robert Wynn
Publisher: Cambridge University Press
Published: 2017-02-16
Total Pages: 299
ISBN-13: 1107439361
DOWNLOAD EBOOKA succinct summary of the key principles and facts that guide the everyday practice of modern, clinical paediatric hematology. Covering all the information necessary for examinations in the topic, this book is ideal for postgraduates studying paediatric hematology, as well as for junior doctors in training.
Thalassemia
Author: Makenzie Greene
Publisher: Nova Science Publishers
Published: 2014
Total Pages: 0
ISBN-13: 9781631179549
DOWNLOAD EBOOKThalassemia is one of the most common genetic disorders worldwide and presents major public health and social challenges in areas of high incidence. The frequency of this disorder varies considerably with geographic locations and racial groups. Thalassemia refers to a group of inherited hemolytic anemia disorders that involve defects in the synthesis of hemoglobin α- or β-polypeptide chains. It leads to decreased hemoglobin production and hypochromic microcytic anemia associated with erythrocyte dysplasia and destruction. Homozygous β-thalassemia (also known as thalassemia major, Cooley's anemia, or Mediterranean anemia) is associated with the most severe signs and symptoms. Thalassemia major (TM) is a life-threatening condition that commonly manifests during early infancy, after which progressive pallor, severe anemia, and failure to thrive are common. Children with TM often develop feeding problems, recurrent fever, bleeding tendencies (especially epistaxis), susceptibility to infection, pathologic fractures of long bones and vertebrae, endocrine abnormalities, splenomegaly, lack of sexual maturation, and growth retardation. This book discusses cures and treatments available for thalassemia, as well as the causes and the type of long-term health outcomes it may cause.
Exploration of Host Genetic Factors associated with Malaria
Author: Tabish Qidwai
Publisher: Springer Nature
Published: 2021-03-08
Total Pages: 174
ISBN-13: 9813347619
DOWNLOAD EBOOKThis book is aimed to cover the role of genetic polymorphisms in human genes related to RBC disorders, metabolic enzymes, immune response, and cytoadherence in the susceptibility/resistance to malaria caused by Plasmodium falciparum. The chapters provide current information on the balancing trait and the significance of such traits in the malaria resistance. The book covers polymorphisms in the genes of the red blood cells-sickle cell anaemia; glucose-6-phosphate dehydrogenase deficiency and thalassemia that confer protection against malaria. In addition, the book explores selection of genetic variations in the human genome as genetic control mechanism against malaria in endemic regions. It also provides a comprehensive overview of the molecular epidemiology and natural selection of alleles in the genes which are associated with malaria, and presents description of the role of human genetic polymorphisms in malaria disease risk and disease outcome.
